{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:45:11Z","timestamp":1791866711316,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jvoice.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:51:37Z","timestamp":1791863497000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Systemic Bevacizumab in Juvenile-Onset Recurrent Respiratory Papillomatosis: An Individual Patient Data Meta-Analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8132-0855","authenticated-orcid":false,"given":"David","family":"Hortobagyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4119-529X","authenticated-orcid":false,"given":"Doris-Maria","family":"Denk-Linnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Valentinuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5219-2428","authenticated-orcid":false,"given":"Tanja","family":"Grossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kaider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kranebitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2026.09.002_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005537-200101000-00011","article-title":"Recurrent respiratory papillomatosis","volume":"111","author":"Derkay","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1258\/ijsa.2010.010073","article-title":"Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children","volume":"21","author":"Donne","year":"2010","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jvoice.2026.09.002_bib3","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/MLG.0b013e31816a7135","article-title":"Recurrent respiratory papillomatosis: a review","volume":"118","author":"Derkay","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/000348949310200802","article-title":"Sites of predilection in recurrent respiratory papillomatosis","volume":"102","author":"Kashima","year":"1993","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/lary.30893","article-title":"Efficacy of systemic bevacizumab for recurrent respiratory papillomatosis with pulmonary involvement","volume":"134","author":"So","year":"2024","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/PHMT.S200186","article-title":"Juvenile-onset recurrent respiratory papillomatosis diagnosis and management \u2013 a developing country review","volume":"11","author":"Seedat","year":"2020","journal-title":"Pediatr Health Med Ther"},{"key":"10.1016\/j.jvoice.2026.09.002_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/life11111279","article-title":"HPV and recurrent respiratory papillomatosis: a brief review","volume":"11","author":"Ouda","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.jvoice.2026.09.002_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-0463.2010.02619.x","article-title":"Epidemiology of recurrent respiratory papillomatosis","volume":"118","author":"Larson","year":"2010","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.jvoice.2026.09.002_bib9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/00005537-199806000-00026","article-title":"A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis","volume":"108","author":"Derkay","year":"1998","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib10","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ijporl.2004.06.007","article-title":"Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis","volume":"68","author":"Derkay","year":"2004","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/0194599816628871","article-title":"Anatomic derkay score is associated with voice handicap in laryngeal papillomatosis in adults","volume":"154","author":"Kupfer","year":"2016","journal-title":"Otolaryngol--Head Neck Surg J Am Acad Otolaryngol-Head Neck Surg"},{"key":"10.1016\/j.jvoice.2026.09.002_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hed.27300","article-title":"Aggressive recurrent respiratory papillomatosis: a series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience","volume":"45","author":"Collette","year":"2023","journal-title":"Head Neck"},{"key":"10.1016\/j.jvoice.2026.09.002_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/lio2.1013","article-title":"Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: one single-center experience of eight patients","volume":"8","author":"Liu","year":"2023","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00106-022-01250-1","article-title":"Rezidivierende larynxpapillomatose","volume":"71","author":"Coordes","year":"2023","journal-title":"HNO"},{"key":"10.1016\/j.jvoice.2026.09.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2019.109706","article-title":"Systemic bevacizumab for end-stage juvenile recurrent respiratory papillomas: a case report","volume":"128","author":"Hamdi","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/hed.23808","article-title":"Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11: clinical course of recurrent respiratory papillomatosis: HPV6 vs HPV11","volume":"37","author":"Tjon Pian Gi","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.jvoice.2026.09.002_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/lio2.132","article-title":"Current and future management of recurrent respiratory papillomatosis","volume":"3","author":"Ivancic","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijporl.2007.12.003","article-title":"Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature","volume":"72","author":"G\u00e9linas","year":"2008","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"7","key":"10.1016\/j.jvoice.2026.09.002_bib19","doi-asserted-by":"crossref","first-page":"EE2277","DOI":"10.1002\/lary.29376","article-title":"Long-term outcomes of Juvenile onset recurrent respiratory papillomatosis with pulmonary involvement","volume":"131","author":"Yang","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103290","article-title":"Global HPV vaccination programs and coverage rates: a systematic review","volume":"84","author":"Han","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jvoice.2026.09.002_bib21","doi-asserted-by":"crossref","first-page":"9071","DOI":"10.1097\/MS9.0000000000004027","article-title":"From surgery to immunotherapy: papzimeos as the first FDA-approved therapy for recurrent respiratory papillomatosis (RRP)","volume":"87","author":"Afridi","year":"2025","journal-title":"Ann Med Surg"},{"issue":"6","key":"10.1016\/j.jvoice.2026.09.002_bib22","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1002\/lary.29343","article-title":"Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement","volume":"131","author":"Sidell","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/000348940511400407","article-title":"Role of vascular endothelial growth factor\u2013a in recurrent respiratory papillomatosis","volume":"114","author":"Vargas","year":"2005","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2021.110737","article-title":"The serum and tissue expression of vascular endothelial growth factor-in recurrent respiratory papillomatosis","volume":"146","author":"Verma","year":"2021","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000348940911800901","article-title":"Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm Pulsed KTP laser treatment of glottal papillomatosis","volume":"118","author":"Zeitels","year":"2009","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/000348941112001001","article-title":"Local Injection of bevacizumab (Avastin) and Angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study","volume":"120","author":"Zeitels","year":"2011","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0029-1214714","article-title":"Behandlung der respiratorischen Papillomatose \u2013 Kasuistik zur systemischen Therapie mit Bevacizumab","volume":"63","author":"Nagel","year":"2009","journal-title":"Pneumologie"},{"key":"10.1016\/j.jvoice.2026.09.002_bib28","first-page":"4229","article-title":"Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review","volume":"279","author":"Pogoda","year":"2022","journal-title":"Eur Arch Oto-Rhino-Laryngol J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg"},{"key":"10.1016\/j.jvoice.2026.09.002_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2019.109697","article-title":"International Pediatric Otolaryngology Group (IPOG): juvenile-onset recurrent respiratory papillomatosis consensus recommendations","volume":"128","author":"Lawlor","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib30","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1002\/lary.31670","article-title":"A consensus statement on the administration of systemic bevacizumab in patients with recurrent respiratory papillomatosis","volume":"134","author":"Best","year":"2024","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib31","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Database Syst Rev Implement Rep"},{"key":"10.1016\/j.jvoice.2026.09.002_bib32","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3892\/ol.2014.2486","article-title":"Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis","volume":"8","author":"Mohr","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jvoice.2026.09.002_bib33","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00405-023-08430-x","article-title":"Systemic bevacizumab for treatment of recurrent respiratory papillomatosis","volume":"281","author":"Zhao","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2021.103126","article-title":"Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: a series of three pediatric cases and literature review","volume":"42","author":"Enrique","year":"2021","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2020.110352","article-title":"Systemic bevacizumab for recurrent respiratory papillomatosis","volume":"138","author":"Baday","year":"2020","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib36","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/lary.30021","article-title":"Systemic bevacizumab treatment for recurrent respiratory papillomatosis: long-term Follow-Up","volume":"132","author":"Ruiz","year":"2022","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib37","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"10.1016\/j.jvoice.2026.09.002_bib38","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lary.26450","article-title":"Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child","volume":"127","author":"Zur","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2026.09.002_bib39","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.21873\/anticanres.16369","article-title":"Relationship between safety and cumulative bevacizumab dose in patients with metastatic colorectal cancer who received long-term bevacizumab treatment","volume":"43","author":"Fukuda","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jvoice.2026.09.002_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0003489414546400","article-title":"Xenograft model for therapeutic drug testing in recurrent respiratory papillomatosis","volume":"124","author":"Ahn","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199726004790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199726004790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:51:41Z","timestamp":1791863501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199726004790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"alternative-id":["S0892199726004790"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2026.09.002","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Systemic Bevacizumab in Juvenile-Onset Recurrent Respiratory Papillomatosis: An Individual Patient Data Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The Voice Foundation.","name":"copyright","label":"Copyright"}]}}